Niagen Bioscience, Inc.

Healthcare · Biotechnology · United States

Last price 2.5 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 198.23M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-gra...